Ashley Welch

All articles by Ashley Welch

• Researchers call for more individualized testing to diagnose systemic mastocytosis

  Relying on BST levels to diagnose SM doesn’t account for individual variability influenced by genetic and physiological factors.

• Current and future therapy options for systemic mastocytosis

  Several newly approved and experimental treatments have shown promise in the management of systemic mastocytosis.

• Genetic trait may heighten anaphylaxis risk for people with SM

  A genetic trait that increases risk of anaphylaxis is higher in people with SM. Identifying the trait early could mean better treatment.

• Targeted therapy brings rapid remission in child with SM-associated leukemia

  The targeted therapy drug gemtuzumab ozogamicin successfully treated a young boy with SM-AHN who did not respond to conventional therapies.

• New study highlights dangers fire ants pose to patients with systemic mastocytosis

  As fire ants spread to more areas, people with SM face a greater risk of severe allergic reactions from fire ant stings.

• New data reaffirms benefits of avapritinib to treat indolent and advanced SM

  Avapritinib treatment improves survival outcomes and symptom management in patients with SM, its maker reported.